Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (261-270 of 317) with videos related to

Pageof 32
Sort By:
Anticancer Research|January 1, 1981
Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trialD F Chiuten, G J Vosika, M T Shaw, et al.
Cancer Treatment Reports|September 1, 1979
Toxic effects of cis-dichlorodiammineplatinum(II) in manD D Von Hoff, R Schilsky, C M Reichert, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1985
Down's syndrome and testicular cancer: a possible associationD L Braun, M D Green, A R Rausen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacologyS C Formenti, P N Shrivastava, M Sapozink, et al.
Cancer Treatment Reports|March 1, 1987
Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancerF M Muggia, F J Camacho, B H Kaplan, et al.
Cancer Treatment Reports|August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agentsD D Von Hoff, M Rozencweig, W T Soper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1984
Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastineL J Laubenstein, R L Krigel, C M Odajnyk, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group studyS M Grunberg, J J Crowley, R B Livingston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2013
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groupsT Safra, W C Lai, L Borgato, et al.
Journal of the National Cancer Institute|October 16, 1996
Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexolF M Muggia, T W Synold, E M Newman, et al.
Pageof 32

Showing results (261-270 of 317) with videos related to

Sort By:
Pageof 32
Anticancer Research|January 1, 1981
Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trialD F Chiuten, G J Vosika, M T Shaw, et al.
Cancer Treatment Reports|September 1, 1979
Toxic effects of cis-dichlorodiammineplatinum(II) in manD D Von Hoff, R Schilsky, C M Reichert, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1985
Down's syndrome and testicular cancer: a possible associationD L Braun, M D Green, A R Rausen, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacologyS C Formenti, P N Shrivastava, M Sapozink, et al.
Cancer Treatment Reports|March 1, 1987
Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancerF M Muggia, F J Camacho, B H Kaplan, et al.
Cancer Treatment Reports|August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agentsD D Von Hoff, M Rozencweig, W T Soper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1984
Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastineL J Laubenstein, R L Krigel, C M Odajnyk, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group studyS M Grunberg, J J Crowley, R B Livingston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2013
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groupsT Safra, W C Lai, L Borgato, et al.
Journal of the National Cancer Institute|October 16, 1996
Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexolF M Muggia, T W Synold, E M Newman, et al.
Pageof 32